id: NEW:anti_seizure_medication_use_aws_to_NEW:rescue_medication_requirement_aws
name: Anti-Seizure Medication Use in Alcohol Withdrawal Syndrome â†’ Rescue Medication
  Requirement in AWS
from_node:
  node_id: NEW:anti_seizure_medication_use_aws
  node_name: Anti-Seizure Medication Use in Alcohol Withdrawal Syndrome
to_node:
  node_id: NEW:rescue_medication_requirement_aws
  node_name: Rescue Medication Requirement in AWS
direction: positive
category: healthcare_access
mechanism_pathway:
- 'Step 1: Anti-seizure medications (ASMs) are administered as primary treatment for
  alcohol withdrawal syndrome (AWS) instead of benzodiazepines'
- 'Step 2: ASMs demonstrate inferior efficacy in controlling AWS symptoms compared
  to benzodiazepines, the current standard of care'
- 'Step 3: Inadequate symptom control with ASMs leads to breakthrough withdrawal symptoms
  requiring additional pharmacological intervention'
- 'Step 4: Patients on ASMs have significantly higher odds (OR: 3.50) of requiring
  rescue medications to manage uncontrolled AWS symptoms'
evidence:
  quality_rating: A
  n_studies: 24
  primary_citation: 'Jou-Yin Lai et al. 2021. The Effectiveness and Tolerability of
    Anti-Seizure Medication in Alcohol Withdrawal Syndrome: A Systematic Review, Meta-Analysis
    and GRADE of the evidence. Addiction.'
  supporting_citations: []
description: Anti-seizure medication use in alcohol withdrawal syndrome is associated
  with a 3.5-fold increase in the odds of requiring rescue medications compared to
  benzodiazepine treatment. This systematic review and meta-analysis of 24 RCTs (n=2223)
  found no evidence supporting ASMs as first-line treatment for AWS, with significantly
  higher rescue medication requirements indicating inferior symptom control.
last_updated: '2025-12-02'
extraction_method: consolidated_batch_v3
quantitative_effects:
  effect_size:
    value: 3.5
    type: odds_ratio
    ci_lower: 1.32
    ci_upper: 9.28
  p_value: 0.012
  sample_size: 2223
moderators:
- name: Comparison group
  direction: strengthens
  strength: strong
  description: The increased rescue medication requirement is specifically observed
    when ASMs are compared to benzodiazepines rather than placebo
- name: Study recency
  direction: weakens
  strength: moderate
  description: Majority of included studies were conducted before 2000, potentially
    limiting applicability to current clinical practice
